The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 by Gorbalenya, Alexander E. et al.
Consensus statement
https://doi.org/10.1038/s41564-020-0695-z
*A list of authors and their affiliations appears at the end of the paper. 
Upon a viral outbreak, it is important to rapidly establish whether the outbreak is caused by a new or a previously known virus (Box 1), as this helps decide which approaches 
and actions are most appropriate to detect the causative agent, con-
trol its transmission and limit potential consequences of the epi-
demic. The assessment of virus novelty also has implications for 
virus naming and, on a different timescale, helps to define research 
priorities in virology and public health.
For many human virus infections such as influenza virus1 or 
norovirus2 infections, well-established and internationally approved 
methods, standards and procedures are in place to identify and 
name the causative agents of these infections and report this infor-
mation promptly to public health authorities and the general public. 
In outbreaks involving newly emerged viruses, the situation may 
be different, and appropriate procedures to deal with these viruses 
need to be established or refined with high priority.
Here, we present an assessment of the genetic relatedness of the 
newly identified human coronavirus3, provisionally named 2019-
nCoV, to known coronaviruses, and detail the basis for (re)naming 
this virus severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), which will be used hereafter. Given the public interest in nam-
ing newly emerging viruses and the diseases caused by these viruses 
in humans, we will give a brief introduction to virus discovery and 
classification — specifically the virus species concept — and the roles 
of different bodies, such as the World Health Organization (WHO) 
and the International Committee on Taxonomy of Viruses (ICTV), in 
this process. We hope this will help readers to better understand the 
scientific approach we have taken to arrive at this name, and we will 
also discuss implications of this analysis and naming decision.
Classifying and naming viruses and virus species
Defining the novelty of viruses is one of the topics that virus 
classification deals with. The classification of RNA viruses needs to 
consider their inherent genetic variability, which often results in two 
or more viruses with non-identical but similar genome sequences 
being regarded as variants of the same virus. This immediately 
poses the question of how much difference to an existing group is 
large enough to recognize the candidate virus as a member of a new, 
distinct group. This question is answered in best practice by evalu-
ating the degree of relatedness of the candidate virus to previously 
identified viruses infecting the same host or established monophy-
letic groups of viruses, often known as genotypes or clades, which 
may or may not include viruses of different hosts. This is formally 
addressed in the framework of the official classification of virus tax-
onomy and is overseen and coordinated by the ICTV4. Viruses are 
clustered in taxa in a hierarchical scheme of ranks in which the spe-
cies represents the lowest and most populous rank containing the 
least diverged groups (taxa) of viruses (Box 2). The ICTV maintains 
a Study Group for each virus family. The Study Groups are respon-
sible for assigning viruses to virus species and taxa of higher ranks, 
such as subgenera, genera and subfamilies. In this context they play 
an important role in advancing the virus species concept and high-
lighting its significance5.
Virus nomenclature is a formal system of names used to label 
viruses and taxa. The fact that there are names for nearly all viruses 
within a species is due to the historical perception of viruses as 
causative agents of specific diseases in specific hosts, and to the way 
we usually catalogue and classify newly discovered viruses, which 
increasingly includes viruses that have not been linked to any known 
disease in their respective hosts (Box 1). The WHO, an agency of the 
United Nations, coordinates international public health activities 
aimed at combating, containing and mitigating the consequences 
of communicable diseases—including major virus epidemics—and 
is responsible for naming disease(s) caused by newly emerging 
human viruses. In doing so, the WHO often takes the traditional 
approach of linking names of specific diseases to viruses (Box 1) and 
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assessing virus novelty by an apparent failure to detect the causative 
agent using established diagnostic assays.
Apart from disease, geography and the organism from which a 
given virus was isolated also dominate the nomenclature, occasion-
ally engraving connections that may be accidental (rather than typi-
cal) or even stigmatizing, which should be avoided. Establishing a 
universal nomenclature for viruses was one of the major tasks of 
the ICTV when it was founded more than 50 years ago4. When the 
species rank was established in the taxonomy of viruses6, ICTV’s 
responsibility for naming viruses was shifted to naming and 
establishing species. ICTV Study Groups may also be involved in 
virus naming on a case-by-case basis as an extension of their offi-
cial remit, as well as using the special expertise of their members. 
As virus species names are often very similar to the name of the 
founding member of the respective species, they are frequently con-
fused in the literature with names of individual viruses in this species. 
The species name is italicized, starts with a capital letter and should 
not be spelled in an abbreviated form7; hence the species name Severe 
acute respiratory syndrome-related coronavirus. In contrast, this 
convention does not apply to virus names, hence severe acute respi-
ratory syndrome coronavirus, or SARS-CoV, as it is widely known.
Defining the place of SARS-CoV-2 within the Coronaviridae
Researchers studying coronaviruses—a family of enveloped pos-
itive-strand RNA viruses infecting vertebrates8—have been con-
fronted several times with the need to define whether a newly 
emerged virus causing a severe or even life-threatening disease in 
humans belongs to an existing or a new (yet-to-be-established) spe-
cies. This happened with SARS9–12 and with Middle East respiratory 
syndrome (MERS)13,14 a few years later. Each time, the virus was 
placed in the taxonomy using information derived from a sequence-
based family classification15,16.
The current classification of coronaviruses recognizes 39 species 
in 27 subgenera, five genera and two subfamilies that belong to the 
family Coronaviridae, suborder Cornidovirineae, order Nidovirales 
and realm Riboviria17–19 (Fig. 1). The family classification and tax-
onomy are developed by the Coronaviridae Study Group (CSG), a 
working group of the ICTV20. The CSG is responsible for assessing 
Box 1 | Virus discovery and naming: from disease-based to phenotype-free
Understanding the cause of a specific disease that spreads among 
individuals of the same host species (infectivity) was the major 
driving force for the discovery of the first virus in plants, and 
subsequently many others in all forms of life, including humans. 
Historically, the range of diseases and hosts that specific viruses 
are associated with have been the two key characteristics used 
to define viruses, given that they are invisible to the naked eye46. 
Viral phenotypic features include those that, like a disease, are pre-
dominantly shaped by virus–host interactions including transmis-
sion rate or immune correlates of protection, and others that are 
largely virus-specific, such as the architecture of virus particles. 
These features are of critical importance to control, and respond 
to medically and economically important viruses — especially 
during outbreaks of severe disease — and dominate the general 
perception of viruses.
However, the host of a given virus may be uncertain, and virus 
pathogenicity remains unknown for a major (and fast-growing) 
proportion of viruses, including many coronaviruses discovered 
in metagenomics studies using next-generation sequencing 
technology of environmental samples47,48. These studies have 
identified huge numbers of viruses that circulate in nature and 
have never been characterized at the phenotypic level. Thus, the 
genome sequence is the only characteristic that is known for 
the vast majority of viruses, and needs to be used in defining 
specific viruses. In this framework, a virus is defined by a genome 
sequence that is capable of autonomous replication inside cells 
and dissemination between cells or organisms under appropriate 
conditions. It may or may not be harmful to its natural host. 
Experimental studies may be performed for a fraction of known 
viruses, while computational comparative genomics is used to 
classify (and deduce characteristics of) all viruses. Accordingly, 
virus naming is not necessarily connected to disease but rather 
informed by other characteristics.
In view of the above advancements and when confronted with 
the question of whether the virus name for the newly identified 
human virus should be linked to the (incompletely defined) disease 
that this virus causes, or rather be established independently from 
the virus phenotype, the CSG decided to follow a phylogeny-based 
line of reasoning to name this virus whose ontogeny can be traced 
in the figure in Box 1.
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the place of new viruses through their relation to known viruses in 
established taxa, including placements relating to the species Severe 
acute respiratorysyndrome-related coronavirus. In the classification 
of nidoviruses, species are considered biological entities demar-
cated by a genetics-based method21, while generally virus species are 
perceived as man-made constructs22. To appreciate the difference 
between a nidoviral species and the viruses grouped therein, it may 
be instructive to look at their relationship in the context of the full 
taxonomy structure of several coronaviruses. Although these viruses 
were isolated at different times and locations from different human 
and animal hosts (with and without causing clinical disease), they 
all belong to the species Severe acute respiratorysyndrome-related 
coronavirus, and their relationship parallels that between human 
individuals and the species Homo sapiens (Fig. 1).
Even without knowing anything about the species concept, every 
human recognizes another human as a member of the same species. 
However, for assigning individual living organisms to most other 
species, specialized knowledge and tools for assessing inter-individ-
ual differences are required. The CSG uses a computational frame-
work of comparative genomics23, which is shared by several ICTV 
Study Groups responsible for the classification and nomenclature 
of the order Nidovirales and coordinated by the ICTV Nidovirales 
Study Group (NSG)24 (Box  3). The Study Groups quantify and 
partition the variation in the most conserved replicative proteins 
encoded in open reading frames 1a and 1b (ORF1a/1b) of the coro-
navirus genome (Fig. 2a) to identify thresholds on pair-wise patris-
tic distances (PPDs) that demarcate virus clusters at different ranks.
Consistent with previous reports, SARS-CoV-2 clusters with 
SARS-CoVs in trees of the species Severe acute respiratory syn-
drome-related coronavirus (Fig. 2b) and the genus Betacoronavirus 
(Fig. 2c)25–27. Distance estimates between SARS-CoV-2 and the most 
closely related coronaviruses vary among different studies depend-
ing on the choice of measure (nucleotide or amino acid) and genome 
region. Accordingly, there is no agreement yet on the exact taxo-
nomic position of SARS-CoV-2 within the subgenus Sarbecovirus. 
When we included SARS-CoV-2 in the dataset used for the most 
recent update (May 2019) of the coronavirus taxonomy currently 
being considered by ICTV19, which includes 2,505 coronaviruses, 
Box 2 | Identifying viral species
The terms strain and isolate are commonly used to refer to virus 
variants, although there are different opinions as to which term 
should be used in a specific context. If a candidate virus clus-
ters within a known group of isolates, it is a variant of this group 
and may be considered as belonging to this known virus group. 
In contrast, if the candidate virus is outside of known groups and 
its distances to viruses in these groups are comparable to those ob-
served between viruses of different groups (intergroup distances), 
the candidate virus is distinct and can be considered novel.
This evaluation is usually conducted in silico using 
phylogenetic analysis, which may be complicated by uneven 
rates of evolution that vary across different virus lineages and 
genomic sites due to mutation, including the exchange of 
genome regions between closely related viruses (homologous 
recombination). However, given that the current sampling of 
viruses is small and highly biased toward viruses of significant 
medical and economic interest, group composition varies 
tremendously among different viruses, making decisions on 
virus novelty group-specific and dependent on the choice of the 
criteria selected for this assessment.
These challenges are addressed in the framework of virus 
taxonomy, which partitions genomic variation above strain or 
isolate level and develops a unique taxon nomenclature under 
the supervision of the ICTV4,5. To decide on whether a virus 
represents a new species—that is, the least diverged (and most 
populated) group of viruses—taxonomists use the results of 
different analyses. Taxonomical classification is hierarchical, 
using nested groups (taxa) that populate different levels (ranks) 
of classification. Taxa of different ranks differ in their intra-taxon 
pairwise divergence, which increases from the smallest at the 
species rank to the largest at the realm rank30. They may also be 
distinguished by taxon-specific markers that characterize natural 
groupings. Only the species and genus ranks need to be specified 
to classify a new virus; filling other ranks is optional. If a virus 
prototypes a new species, it will be regarded as taxonomically 
novel. If (within this framework) a virus crosses a host barrier 
and acquires novel properties, its classification will not change 
(that is, it remains part of the original species) even if the virus 
establishes a permanent circulation in the new host, which likely 
happened with coronaviruses of the four species that circulate 
in humans and display seasonal peaks (reviewed in ref. 50). 
Importantly, the criteria used to define a viral species in one 
virus family such as Coronaviridae may not be applicable to 
another family such as Retroviridae, and vice versa, since Study 
Groups are independent in their approach to virus classification.
Box 3 | Classifying coronaviruses
Initially, the classification of coronaviruses was largely based on 
serological (cross-) reactivities to the viral spike protein, but is 
now based on comparative sequence analyses of replicative pro-
teins. The choice of proteins and the methods used to analyse 
them have gradually evolved since the start of this century20,28,29,51. 
The CSG currently analyses 3CLpro, NiRAN, RdRp, ZBD and 
HEL1 (ref. 52) (Fig. 2a), two domains less than previously used 
in the analyses conducted between 2009 and 2015 (refs. 16,18). 
According to our current knowledge, these five essential do-
mains are the only ones conserved in all viruses of the order Ni-
dovirales52. They are thus used for the classification by all ICTV 
nidovirus study groups (coordinated by the NSG).
Since 2011, the classification of coronaviruses and other 
nidoviruses has been assisted by the DivErsity pArtitioning 
by hieRarchical Clustering (DEmARC) software, which 
defines taxa and ranks23,24. Importantly, the involvement of all 
coronavirus genome sequences available at the time of analysis 
allows family-wide designations of demarcation criteria for all 
ranks, including species, regardless of the taxa sampling size, 
be it a single or hundreds of virus(es). DEmARC delineates 
monophyletic clusters (taxa) of viruses using weighted linkage 
clustering in the PPD space and according to the classification of 
ranks defined through clustering cost (CC) minima presented as 
PPD thresholds (PPD accounts for multiple substitutions at all 
sequence positions and thus may exceed 1.0, which is the limit 
for conventional pair-wise distances (PDs)). In the DEmARC 
framework, the persistence of thresholds in the face of increasing 
virus sampling is interpreted to reflect biological forces and 
environmental factors21. Homologous recombination, which 
is common in coronaviruses53–55, is believed to be restricted in 
genome regions encoding the most essential proteins, such as 
those used for classification, and to members of the same virus 
species. This restriction promotes intra-species diversity and 
contributes to inter-species separation. To facilitate the use 
of rank thresholds outside of the DEmARC framework, they 
are converted into PD and expressed as a percentage, which 
researchers commonly use to arrive at a tentative assignment 
of a given virus within the coronavirus taxonomy following 
conventional phylogenetic analysis of selected viruses.
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the species composition was not affected and the virus was assigned 
to the species Severe acute respiratory syndrome-related coronavirus, 
as detailed in Box 4.
With respect to novelty, SARS-CoV-2 differs from the two other 
zoonotic coronaviruses, SARS-CoV and MERS-CoV, introduced 
to humans earlier in the twenty-first century. Previously, the CSG 
established that each of these two viruses prototype a new species 
in a new informal subgroup of the genus Betacoronavirus15,16. These 
two informal subgroups were recently recognized as subgenera 
Sarbecovirus and Merbecovirus18,28,29 when the subgenus rank was 
established in the virus taxonomy30. Being the first identified repre-
sentatives of a new species, unique names were introduced for the 
two viruses and their taxa in line with the common practice and state 
of virus taxonomy at the respective times of isolation. The situation 
with SARS-CoV-2 is fundamentally different because this virus is 
assigned to an existing species that contains hundreds of known 
viruses predominantly isolated from humans and diverse bats. All 
these viruses have names derived from SARS-CoV, although only 
the human isolates collected during the 2002–2003 outbreak have 
been confirmed to cause SARS in infected individuals. Thus, the 
reference to SARS in all these virus names (combined with the use 
of specific prefixes, suffixes and/or genome sequence IDs in pub-
lic databases) acknowledges the phylogenetic (rather than clinical 
disease-based) grouping of the respective virus with the prototypic 
virus in that species (SARS-CoV). The CSG chose the name SARS-
CoV-2 based on the established practice for naming viruses in this 
species and the relatively distant relationship of this virus to the pro-
totype SARS-CoV in a species tree and the distance space (Fig. 2b 
and the figure in Box 4).
The available yet limited epidemiological and clinical data for 
SARS-CoV-2 suggest that the disease spectrum and transmission 
efficiency of this virus31–35 differ from those reported for SARS-
CoV9. To accommodate the wide spectrum of clinical presentations 
and outcomes of infections caused by SARS-CoV-2 (ranging from 
asymptomatic to severe or even fatal in some cases)31, the WHO 
recently introduced a rather unspecific name (coronavirus disease 
19, also known as COVID-19 (ref. 36)) to denote this disease. Also, 
the diagnostic methods used to confirm SARS-CoV-2 infections are 
not identical to those of SARS-CoV. This is reflected by the specific 
recommendations for public health practitioners, healthcare work-
ers and laboratory diagnostic staff for SARS-CoV-2 (for example, 
the WHO guidelines for SARS-CoV-2 (ref. 37). By uncoupling the 
naming conventions used for coronaviruses and the diseases that 
some of them cause in humans and animals, we wish to support the 
WHO in its efforts to establish disease names in the most appro-
priate way (for further information, see the WHO’s guidelines for 
disease naming38). The further advancement of naming conventions 
is also important because the ongoing discovery of new human and 
animal viruses by next-generation sequencing technologies can be 
expected to produce an increasing number of viruses that do not 
(easily) fit the virus–disease model that was widely used in the pre-
genomic era (Box 1). Having now established different names for 
the causative virus (SARS-CoV-2) and the disease (COVID-19), the 
CSG hopes that this will raise awareness in both the general public 
and public health authorities regarding the difference between these 
two entities. The CSG promotes this clear distinction because it will 
help improve the outbreak management and also reduces the risk of 
confusing virus and disease, as has been the case over many years 
with SARS-CoV (the virus) and SARS (the disease).
To facilitate good practice and scientific exchange, the CSG rec-
ommends that researchers describing new viruses (that is, isolates) 
in this species adopt a standardized format for public databases and 
publications that closely resembles the formats used for isolates of 
avian coronaviruses39, filoviruses40 and influenza virus1. The pro-
posed naming convention includes a reference to the host organism 
that the virus was isolated from, the place of isolation (geographic 
location), an isolate or strain number, and the time of isolation (year 
or more detailed) in the format virus/host/location/isolate/date; for 
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OrF1a/b-encoded domains and other major OrFs in the SArS-coV genome. 5d, 5 domains: nsp5A-3cLpro, two beta-barrel domains of the 3c-like protease; 
nsp12-NirAN, nidovirus rdrp-associated nucleotidyltransferase; nsp12-rdrp, rNA-dependent rNA polymerase; nsp13-hEL1 core, superfamily 1 helicase with 
upstream Zn-binding domain (nsp13-ZBD); nt, nucleotide. b, The maximum-likelihood tree of SArS-coV was reconstructed by IQ-TrEE v.1.6.1 (ref. 45) using 83 
sequences with the best fitting evolutionary model. Subsequently, the tree was purged from the most similar sequences and midpoint-rooted. Branch support 
was estimated using the Shimodaira–hasegawa (Sh)-like approximate likelihood ratio test with 1,000 replicates. GenBank IDs for all viruses except four are 
shown; SArS-coV, AY274119.3; SArS-coV-2, MN908947.3; SArSr-coV_BtKY72, KY352407.1; SArS-coV_Pc4-227, AY613950.1. c, Shown is an IQ-TrEE 
maximum-likelihood tree of single virus representatives of thirteen species and five representatives of the species Severe acute respiratory syndrome-related 
coronavirus of the genus Betacoronavirus. The tree is rooted with hcoV-NL63 and hcoV-229E, representing two species of the genus Alphacoronavirus. Purple 
text highlights zoonotic viruses with varying pathogenicity in humans; orange text highlights common respiratory viruses that circulate in humans. Asterisks 
indicate two coronavirus species whose demarcations and names are pending approval from the IcTV and, thus, these names are not italicized.
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Box 4 | Classifying SARS-CoV-2
The species demarcation threshold (also known as demarcation 
limit) in the family Coronaviridae is defined by viruses whose 
PPD(s) may cross the inter-species demarcation PPD threshold 
(threshold ‘violators’). Due to their minute share of ~10–4 of the to-
tal number of all intra- and inter-species PPDs, these violators may 
not even be visually recognized in a conventional diagonal plot clus-
tering viruses on a species basis (panel a of the figure in Box 4). 
Furthermore, they do not involve any virus of the species Severe 
acute respiratory syndrome-related coronavirus, as is evident from 
the analysis of maximal intraspecies PPDs of 2,505 viruses of all 49 
coronavirus species (of which 39 are established and 10 are pending 
or tentative) (panel b of the figure in Box 4) and PDs of 256 viruses 
of this species (panel c of the figure in Box 4). Thus, the genomic 
variation of the known viruses of the species Severe acute respiratory 
syndrome-related coronavirus is smaller compared to that of other 
comparably well-sampled species—for example, those prototyped 
by MERS-CoV, human coronavirus OC43 (HCoV-OC43) and in-
fectious bronchitis virus (IBV) (panel b of the figure in Box 4)—and 
this species is well separated from other known coronavirus species 
in the sequence space. Both of these characteristics facilitate the un-
ambiguous assignment of SARS-CoV-2 to this species.
Intra-species PDs of SARS-CoV-2 belong to the top 25% of this 
species and also include the largest PD between SARS-CoV-2 and 
an African bat virus isolate (SARSr-CoV_BtKY72)56 (panel c of 
the figure in Box 4), representing two basal lineages within the 
species Severe acute respiratory syndrome-related coronavirus that 
constitute very few known viruses (Fig. 2b,c). These relationships 
stand in contrast to the shallow branching of the most populous 
lineage of this species, which includes all the human SARS-CoV 
isolates collected during the 2002–2003 outbreak and the closely 
related bat viruses of Asian origin identified in the search for the 
potential zoonotic source of that epidemic57. This clade structure 
is susceptible to homologous recombination, which is common in 
this species44,58,59; to formalize clade definition, it must be revisited 
after the sampling of viruses representing the deep branches has 
improved sufficiently. The current sampling defines a very small 
median PD for human SARS-CoVs, which is approximately 15 
times smaller than the median PD determined for SARS-CoV-2 
(0.16% versus 2.6%; panel c of the figure in Box 4). This small 
median PD of human SARS-CoVs also dominates the species-
wide PD distribution (0.25%; panel c of the figure in Box 4).
Pairwise distance demarcation of species in the family Coronaviridae. a, 
Diagonal matrix of PPDs of 2,505 viruses clustered according to 49 coronavirus 
species, 39 established and 10 pending or tentative, and ordered from the 
most to least populous species, from left to right; green and white, PPDs 
smaller and larger than the inter-species threshold, respectively. Areas of the 
green squares along the diagonal are proportional to the virus sampling of 
the respective species, and virus prototypes of the five most sampled species 
are specified to the left; asterisks indicate species that include viruses whose 
intra-species PPDs crossed the inter-species threshold (threshold ‘violators’). b, 
Maximal intra-species PPDs (x axis, linear scale) plotted against virus sampling 
(y axis, log scale) for 49 species (green dots) of the Coronaviridae. Indicated 
are the acronyms of virus prototypes of the seven most sampled species. 
Green and blue plot sections represent intra-species and intra-subgenera PPD 
ranges. The vertical black line indicates the inter-species threshold. c, Shown 
are the PDs of non-identical residues (y axis) for four viruses representing 
three major phylogenetic lineages (clades) of the species Severe acute 
respiratorysyndrome-related coronavirus (panel b) and all pairs of the 256 
viruses of this species (‘all pairs’). The PD values were derived from 
pairwise distances in the MSA that were calculated using an identity matrix. 
Panels a and b were adopted from the DEmArc v.1.4 output.
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example, SARS-CoV-2/human/Wuhan/X1/2019. This complete 
designation along with additional and important characteristics, 
such as pathogenic potential in humans or other hosts, should be 
included in the submission of each isolate genome sequence to pub-
lic databases such as GenBank. In publications, this name could 
be further extended with a sequence database ID—for example, 
SARS-CoV-2/human/Wuhan/X1/2019_XYZ12345 (fictional exam-
ple)—when first mentioned in the text. We believe that this format 
will provide critical metadata on the major characteristics of each 
particular virus isolate (genome sequence) required for subsequent 
epidemiological and other studies, as well as for control measures.
expanding the focus from pathogens to virus species
Historically, public health and fundamental research have been 
focused on the detection, containment, treatment and analysis of 
viruses that are pathogenic to humans following their discovery 
(a reactive approach). Exploring and defining their biological char-
acteristics in the context of the entire natural diversity as a spe-
cies has never been a priority. The emergence of SARS-CoV-2 as a 
human pathogen in December 2019 may thus be perceived as com-
pletely independent from the SARS-CoV outbreak in 2002–2003. 
Although SARS-CoV-2 is indeed not a descendent of SARS-CoV 
(Fig. 2b), and the introduction of each of these viruses into humans 
was likely facilitated by independent unknown external factors, the 
two viruses are genetically so close to each other (Fig. 2c, panel c of 
the figure in Box 4) that their evolutionary histories and character-
istics are mutually informative.
The currently known viruses of the species Severe acute respi-
ratory syndrome-related coronavirus may be as (poorly) repre-
sentative for this particular species as the few individuals that we 
selected to represent H. sapiens in Fig. 1. It is thus reasonable to 
assume that this biased knowledge of the natural diversity of the 
species Severe acute respiratory syndrome-related coronavirus limits 
our current understanding of fundamental aspects of the biology 
of this species and, as a consequence, our abilities to control zoo-
notic spillovers to humans. Future studies aimed at understanding 
the ecology of these viruses and advancing the accuracy and reso-
lution of evolutionary analyses41 would benefit greatly from adjust-
ing our research and sampling strategies. This needs to include an 
expansion of our current research focus on human pathogens and 
their adaptation to specific hosts to other viruses in this species. 
To illustrate the great potential of species-wide studies, it may 
again be instructive to draw a parallel to H. sapiens, and specifi-
cally to the impressive advancements in personalized medicine in 
recent years. Results of extensive genetic analyses of large num-
bers of individuals representing diverse populations from all con-
tinents have been translated into clinical applications and greatly 
contribute to optimizing patient-specific diagnostics and therapy. 
They were instrumental in identifying reliable predictive markers 
for specific diseases as well as genomic sites that are under selec-
tion. It thus seems reasonable to expect that genome-based analy-
ses with a comparable species coverage will be similarly insightful 
for coronaviruses. Also, additional diagnostic tools that target the 
entire species should be developed to complement existing tools 
optimized to detect individual pathogenic variants (a proactive 
approach). Technical solutions to this problem are already avail-
able; for example, in the context of multiplex PCR-based assays42. 
The costs for developing and applying (combined or separate) spe-
cies- and virus-specific diagnostic tests in specific clinical and/or 
epidemiological settings may help to better appreciate the biologi-
cal diversity and zoonotic potential of specific virus species and 
their members. Also, the further reduction of time required to 
identify the causative agents of novel virus infections will contrib-
ute to limiting the enormous social and economic consequences of 
large outbreaks. To advance such studies, innovative fundraising 
approaches may be required.
Although this Consensus Statement focuses on a single virus 
species, the issues raised apply to other species in the family and 
possibly beyond. A first step towards appreciation of this species 
and others would be for researchers, journals, databases and other 
relevant bodies to adopt proper referencing to the full taxonomy 
of coronaviruses under study, including explicit mentioning of the 
relevant virus species and the specific virus(es) within the species 
using the ICTV naming rules explained above. This naming con-
vention is, regretfully, rarely observed in common practice, with 
mixing of virus and species names being frequently found in the 
literature (including by the authors of this Consensus Statement 
on several past occasions). The adoption of accurate virus-naming 
practices should be facilitated by the major revision of the virus spe-
cies nomenclature that is currently being discussed by the ICTV 
and is being planned for implementation in the near future43. With 
this change in place, the CSG is resolved to address the existing sig-
nificant overlap between virus and species names that complicates 
the appreciation and use of the species concept in its application to 
coronaviruses.
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